Podcast Index
Parcourez les podcasts par catégorie, ouvrez les épisodes récents et téléchargez l’audio pour l’écouter hors ligne.
Decera Clinical Education Oncology Podcast
Decera Clinical Education
Tässä olen - hengellisiä harjoituksia
Suomen Pipliaseura
IELTS Speaking for Success
Podcourses
ODAAT Gambling Awareness
ODAAT Gambling Awareness
עלונימייל | Alonimail
Alonimail
哇賽心理學
哇賽心理學
مُلخص كتاب
Podcast Record
موسوعة الكتب الصوتية
Podcast Record
FinPod
Corporate Finance Institute
U.S. Citizenship Interview Podcast
Howen Media
Is It My Time? with CindyLynn - Personal Healing/Growth, Study of God’s Word
CindyLynn, LLC
Inside Learning | Unlocking human potential
The Learnovate Centre, Trinity College Dublin
Next Day Prep
WaveRider: Where Traders Prep for Tomorrow’s Moves
Rogue Soul
Lindsey Scharmyn
Ad Navseam
Ad Navseam
Awakening Women Podcast
Leanne Oaten
@theBar
Legal Talk Network
早安英文
早安英文
Pastor Tony Kapola
Pastor Tony Kapola
The Kings Code Podcast
Tate
The Lifeonaire Show
Lifeonaire.com
The Elisha Show: Purpose Driven Life & Mastery
Elisha Arowojobe | Personal Mastery & Purpose Coach
Lifelong Learning With A. A. Khatana
A.A. Khatana
The Sonoma Spiel
Sonoma Valley Visitors Bureau
Walking with Jesus with Pastor Doug Anderson Podcast
Pastor Doug Anderson
Woo Woo Wednesday
Renee Dick
Pensieve - Benjamin Ross
Benjamin Ross
Lana Blakely
Lana Blakely
What's a Jew to Do
Rabbi Menachem Siderson
Piedzīvot lappuses
Aija Bremšmite
雅思口语IELTS English2026
英语口语家森Jason
雅思口语新周刊 English Podcast
雅思口语家森Jason
ไวท์พอดคาสต์ #WhitePodcast | White Channel | ไวท์แชนแนล
whitesocial
Unprofessionalism
Dr Myriam Hadnes
Singing Teachers Talk
BAST Training
The Salty Pastor
Dr. Douglas Peake
Mana pro tento den
Scripture Union ČR
Éducation
Decera Clinical Education
Listen in to learn from Cristina Saura Manich, MD, PhD and Giampaolo Bianchini, MD about practical approaches to PI3K pathway testing, PI3K/AKT-targeted treatment options, and endocrine-based sequencing in metastatic bre...
Link to claim CME credit: https://bit.ly/4uRr3ir In this episode, Elizabeth Krueger, NP, and Sam Vafadar, DHSc, PA-C, discuss how they optimize first-line EGFR-targeted therapy for patients with EGFR-mutated NSCLC, inclu...
In this episode, Dr Abbie Begnaud discusses the importance of lung cancer screening and evolving strategies to improve early detection among high-risk populations, including: Low-dose CT screening, which reduces lung c...
In this episode, Aarti Bhatia, MD, MPH, and Deborah J. Wong, MD, PhD, discuss the rapidly evolving treatment landscape for recurrent, metastatic, and locally advanced head and neck squamous cell carcinoma (HNSCC), incl...
In this episode, hear Doris K. Hansen, MD, discuss the management of relapsed/refractory multiple myeloma with bispecific antibodies including: Practical differences among approved bispecific antibodies Toxicity profi...
In this episode, Muhamed Baljevic, MD, FACP, and Johnathan Ticku, MD, discuss various strategies to optimize the use of bispecific antibodies in their practices for the treatment of R/R MM through patient monitoring, dos...
In this episode, hear Anthony Hunter, MD and Douglas Tremblay, MD discuss the various presentations of thrombotic events in patients with PV or ET including how thrombotic events may lead to diagnosis: PV and ET incre...
In this podcast episode, Ciro Rinaldi MD, PhD, and Alessandro M. Vannucchi, MD, discuss contemporary management of essential thrombocythemia (ET) and polycythemia vera (PV), as well as novel investigational approaches, i...
In this podcast episode, Ciro Rinaldi, MD, PhD, and Alessandro M. Vannucchi, MD, as they discuss contemporary topics in diagnosing essential thrombocythemia (ET) and polycythemia vera (PV), including: Overview of diagn...
In this podcast episode, Erika Hamilton, MD, FASCO, and Ian Krop, MD, PhD, discuss recent developments in the field of first-line therapy and maintenance treatment for patients with HER2-positive metastatic breast cancer...
A patient advocate/cancer survivor and a healthcare professional discuss key topics including early breast cancer diagnosis, role of self-agency in pursuing optimal cancer care, encouraging trial participation with patie...
Podcast with global experts discussing the role of AKT and PI3K inhibitors in patients with resistance to endocrine therapy in the adjuvant or metastatic disease settings following current guidelines, indications, and be...
In this episode, Danielle Roman, PharmD, BCOP, and Jordan Hill, PharmD, BCOP, discuss patient-centered management of CDK4/6 inhibitor therapy in HR-positive/HER2-negative breast cancer, with a focus on how oncology pharm...
In this episode, Dr Matthew Gubens and Dr Helena Yu discuss the evolving role of TROP2-directed therapies in non-small-cell lung cancer, with a focus on how antibody–drug conjugates (ADCs) fit into current treatment stra...
In this podcast episode, Amit Mahipal, MD, MPH, and Shubham Pant, MD, discuss new and emerging therapies for the individualized care of patients with HER2-positive gastroesophageal adenocarcinoma and biliary tract cancer...
In this podcast episode, Aditya Bardia, MD, MPH, FASCO, and Ruta Rao, MD, discuss ADCs for HER2-negative/ultralow/low metastatic breast cancer, including: Classifying HER2 expression in MBC today (HER2 negative/ultralo...
Advanced practice providers discuss biomarker testing in patients with colorectal cancer. Listen in to learn from Ann Marie Siney, RN, MSN, ANP-BC, and Kathleen Boyle, DScPAS, PA-C, about familial cancer syndromes associ...
Listen to this audio podcast covering biomarker testing in patients with prostate cancer. Learn from Sara Traverso, MMS, PA-C, and Brenda Martone, MSN, ANP-BC, AOCNP, about when to conduct germline and somatic genetic te...
In this episode, Sam S. Chang, MD, MBA, and Matthew D. Galsky, MD, discuss the rapidly evolving treatment landscape in bladder cancer, highlighting new therapeutic options, emerging clinical trial data, including the lat...
In this episode, oncology pharmacists Julia L. Ziegengeist, PharmD, BCOP, and Rodney Hunter, PharmD, BCOP, explore and challenge common assumptions about adjuvant CDK4/6 inhibitor use in high-risk HR+/HER2- early breast ...
Remplissez le formulaire ci-dessous. Veillez à sélectionner à la fois Pays et Genres.
Envoyez-nous un message ci-dessous. Nous vous répondrons dans les 24 heures.